Our executive team is comprised of experienced healthcare providers and executives who have successfully brought leading drug therapeutics and clinical decision-making technologies to the forefront.
Sal J. Rafanelli, RPh
President & CEO
Sal Rafanelli is a visionary health care Executive Leader with a multifaceted background as a Pharmacist, Serial Entrepreneur, and Healthcare Innovator. With a deep-rooted passion for revolutionizing the healthcare landscape, Sal has consistently embarked on entrepreneurial journeys aimed at addressing critical issues within the pharmaceutical / medical device industry related to clinical outcomes as well as the delivery of better care to patients in an efficient cost-effective model. His companies have focused on extensive expertise in drug protocol development, Pharmacoeconomics, drug delivery, clinical care, and patient experience enhancement has significantly reshaped the way healthcare is delivered.
Sal's impressive track record speaks for itself, as he has successfully founded and led three distinct companies within the infusion and specialty pharmacy sector. Through his unwavering dedication and strategic acumen, he not only pioneered solutions that transformed drug delivery and patient care but also navigated these companies to remarkable financial success. With a remarkable entrepreneurial spirit, Sal orchestrated the strategic sale of all three ventures to either public corporations or private equity firms, amassing an impressive cumulative valuation exceeding $220 million.
Joe Bissonnette, CPA
Chief Financial Officer
Joseph C. Bissonnette’s extensive background covers 42 years in the accounting, tax and business consulting fields. For the first 15 years of his career, he focused on audit, controllerships and financial management positions in various industries prior. Mr. Bissonnette later founded his own firm and remains the sole owner of Joseph C. Bissonnette & Co. CPAs, and a partner at Audibert, Bissonnette & Co. CPAs. His specific expertise lies in the areas of financial analysis and business planning, tax and accounting issues, and management consulting. Mr. Bissonnette graduated from the University of Connecticut School of Business with a bachelor’s degree in accounting and taxation.
Chief Technology Officer
Scott Kalcic has more than 25 years of information technology management and consulting experience with extensive knowledge in IT operations management, systems implementation, security, and regulatory compliance. Mr. Kalcic studied Business Management and Info Systems Programming at Purdue University and started his professional career at Price Waterhouse (PW) where he worked in internal accounting. While at PW he had the opportunity to assist in the management of their departmental network server system. This fueled his enthusiasm to become a certified network engineer and led to a successful career as a senior-level information technology executive.
Melanie Rosenblatt, MD
Dr. Melanie Rosenblatt, MD, is a distinguished expert renowned for her invaluable contributions to the field of medicine and the legal domain. With a profound understanding of both medical science and law, Dr. Rosenblatt has become an indispensable resource in the fight against the opioid crisis. Serving as an expert consultant for esteemed organizations such as the Drug Enforcement Administration (DEA), the Federal Bureau of Investigation (FBI), and major players within the Pharmaceutical Industry, she has played a pivotal role in the national opioid litigation. Dr. Rosenblatt's expertise in pharmacology, pain management, and addiction has been instrumental in providing crucial insights and evidence during high-profile legal proceedings. Her unwavering dedication to promoting public health, preventing substance abuse, and seeking justice has earned her widespread recognition as a leading authority in the battle against the opioid epidemic.
Shelley Halligan, DNP, MSN, PMHNP-BC
Executive Clinical Consultant
Shelley Halligan, DNP, MSN, PMHNP-BC is an experienced psychiatric nurse practitioner with over 20 years of experience in the field of addiction medicine. She is currently the Executive Clinical Consultant for Speranza Therapeutics focusing on medical trials, research opportunities, and growth. Her extensive knowledge and experience have allowed her many research opportunities and publications with Yale, University of Massachusetts Amherst, and Emory University. Dr Halligan is a subject matter expert in the area of detox and medical conditions that accompany substance use disorder. Dr Halligan has dedicated her career to focus on addiction medicine and working with organizations whose mission is focused on treatment with long standing results for the patients and families. Dr Halligan is a person in long term recovery, so she can speak both languages of patient and provider. Dr Halligan is an expert speaker and has been featured in many publications, podcast, and television appearences. She practices a holistic, harm reduction, client centered approach to treating addiction.
Vice President Payer Relations
Patient access to U.S. healthcare has always been at the front and center of Rob’s career. He spent the recent 25 years securing access to care to improve the well-being of the patient in executive roles in organ transplant and opioid dependence. Rob was head of Market Access at Indivior (9 years) and Veloxis (7 years). Since his days overseeing payer access strategy for opioid use disorder, Rob’s ideals have always placed the patient at the forefront of every decision. He firmly believes in OUD as a disease, and he accepts all challenges to improve a patient's life in treatment.
Key Opinion Leaders
Flora Sadri-Azarbayejani, D.O., MPH, FAAFP, FASAM
Flora Sadri-Azarbayejani's journey in the field of healthcare began at Boston University, where she earned her undergraduate degree in biomedical engineering. Her thirst for knowledge and commitment to making a difference led her to complete a remarkable educational journey, culminating in her becoming a prominent medical professional.
After her undergraduate studies, Dr. Sadri-Azarbayejani pursued dual master's degrees at Boston University, specializing in epidemiology and biostatistics, and medical science. She then attained her doctorate in medicine from the University of New England College of Osteopathic Medicine, showcasing her dedication to a well-rounded education in the medical field.
Dr. Sadri-Azarbayejani's professional career commenced as an epidemiologist in infectious disease at the Massachusetts Department of Public Health. Her expertise in this critical area laid the foundation for her future contributions to public health.